Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: May 19, 2011

Premium

Regulus Therapeutics said it has named Mary Glanville as its senior vice president of human capital and Christopher Aker as its senior director of legal affairs and secretary.

Glanville will be responsible for employee recruitment and retention, as well as aligning staff with the company's business needs. She joins Regulus from Anadys Pharmaceuticals where she led human resources.

Aker will handle all of Regulus' legal, corporate, and intellectual property matters, the company said. He previously served as corporate counsel and senior director of administration at Phenomix, a now shuttered drug developer.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.